# Fundamentals #0010: Vertex Pharmaceuticals filing; insider transactions

Date: 2026-10-21 10:10
URL: https://heniu.blog/en/f-log/flog-2026-10-21-0010/
Author: Heniu (heniu.blog). Text license: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/).

---


Vertex Pharmaceuticals (VRTX) filed a report of changes in management or board of directors.

Insiders sold shares for 26.1 million USD, including 26.1 million USD from 10b5-1 plans; market purchases amounted to 25 thousand USD. The largest sale was reported by Micron Technology (MU) insiders: 25.7 million USD.

The President, Chief Technology Officer, and Chief Operating Officer of Micron Technology (MU) sold 28,545 shares valued at 25.7 million USD under a 10b5-1 plan.

The Executive Vice President, Chief Financial Officer, and Chief Operating Officer of QUALCOMM (QCOM) sold 2,500 shares valued at 0.4 million USD under a 10b5-1 plan.